Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Medical Research Center for Hematology (NMRC for Hematology) is Russia's premier federal institution for blood disease research and clinical care, currently led by General Director Elena N. Parovichnikova. The center is the primary developer of national clinical guidelines and coordinates extensive multicenter trial protocols for hematological malignancies, most notably the Ru-AML and Ru-ALL series. It provides advanced medical services, including high-dose chemotherapy and hematopoietic stem cell transplantation, while conducting R&D in molecular genetics, immunology, and transfusion medicine. As a central reference hub, it plays a critical role in standardizing hematological treatment and coordinating a network of regional centers across the Russian Federation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elena N. Parovichnikova.